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ABSTRACT
Background Direct-to-consumer (DTC) advertisements for medication communicate a dis-
tinct image of illness and have the potential to shape how we understand what constitutes
illness. 
Analysis The purpose of this study was to explore discursive patterns in how women interact
with the messages related to depression in DTC television advertisements for antidepressants.
We conducted six focus groups of 1 to 2 hours, with 4 to 6 female participants per group.
Within each group, participants viewed and discussed 2 to 3 DTC advertisements. 
Conclusions and implications Using discourse analysis to explore how the women engaged
with the messages in the advertisements, we show how participants reclaimed what consti-
tutes “normal” and “depression” and often positioned the ads as falling short in their presen-
tations of these categories.
Keywords Antidepressants; Discourse analysis; Advertisement; Depression
RÉSUMÉ
Contexte  La publicité directe au consommateur (PDC) sur les médicaments véhicule une
image particulière de la maladie qui peut inﬂéchir notre avis sur ce qu’est celle-ci.
Analyse  L’objectif de cette étude était d’explorer des structures discursives relatives à la
manière dont les femmes perçoivent les messages sur la dépression communiqués par des
PDC sur les antidépresseurs. Pour ce faire, nous avons mené six groupes de discussion d’une à
deux heures comptant 4 à 6 femmes par groupe. Au sein de chaque groupe, les participantes
ont regardé et commenté 2 ou 3 PDC.
Conclusion et implications  Nous avons effectué une analyse du discours aﬁn d’explorer la
manière dont les femmes interprètent les messages des PDC. Nous montrons comment les
participantes se sont accordées sur le sens de « normal » et de « dépression » tout en percevant
les PDC comme inadéquats dans leur présentation de ces concepts.
Mots clés  Antidépresseurs; Analyse du discours; Publicité; Dépression
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Currently, there are two countries—the United States (U.S.) and New Zealand—that
allow direct-to-consumer (DTC) advertisements for prescription drugs (Mintzes, 2006).
In Canada, the only types of prescription drug advertisements permitted are reminder
advertisements (i.e., those in which the medication is mentioned but not what it
“treats”) and “disease-oriented or help-seeking advertisements” (i.e., those that do
not mention a  speciﬁc form of treatment, but communicate health information, in-
cluding promoting discussion with a physician; Mintzes, 2006, p.  1). Although these
regulations are in place, various loopholes result in Canadians being exposed to DTC
advertisements (Mintzes, 2006). In a study where DTC drug advertisement exposure
rates in the U.S. were compared to those in Canada, Mintzes, Barer, Kravitz, Bassett,
Lexchin, Kazanjian, Evans, Pan, and Marion (2003) argued that, though the U.S. pop-
ulation experienced higher exposure, Canadians still reported exposure, and exposure
was related to more requests for the advertised medication in both populations. Some
researchers have indicated that women can be considered a target audience for these
types of advertisements (Brownﬁeld, Bernhardt, Phan, Williams, & Parker, 2013),
which is unsurprising in the context of advertisements for medications such as anti-
depressants, since Pratt, Brody, and Gu (2011) have demonstrated that women are
more likely to use antidepressants. As such, discussion of DTC advertisements is rele-
vant within a Canadian context, and consideration of how women, in particular, en-
gage with advertisements for antidepressants is especially pertinent.
Although there is evidence that individuals do not consume health messages pas-
sively (Lock, 2012), some researchers argue that DTC drug advertisements can impact
the public. For example, Singh and Smith (2005) indicated that just under half their
sample reported having sought information about a drug after having viewed an ad-
vertisement. Further, just under 20 percent of their sample reported having asked their
doctor about a brand of medication after having viewed an advertisement, with slightly
less than 60 percent of that number reporting physician compliance. Similarly, other
researchers have found that DTC drug advertisement spending and/or exposure was
associated with increased visits to physicians, including for the purpose of inquiring
about, requesting, or attaining a medication (Bell, Taylor, & Kravitz, 2010; Iizuka &
Jin, 2005; Joseph, Spake, & Finney, 2008). At the same time, researchers have high-
lighted that consumers are skeptical or sometimes critical of the information presented
in DTC drug advertisements, and that individuals pay varying levels of attention to
and have diverse types of engagement with these advertisements (Alperstein, 2014;
Arney, Street, & Naik, 2013; Bell et  al., 2010; Joseph et  al., 2008).
Critics have also argued that the pharmaceutical industry, including through DTC
drug advertisements, “disease mongers” and medicalizes (Arney & Menjivar, 2014;
Conrad, 1992, 2005; Healy, 2006; Moynihan, Heath, & Henry, 2002), and that it focuses
on a biomedical model of illness (Greenslit & Kaptchuk, 2012; Grow, Park, & Han,
2006). Disease mongering and medicalization are two related concepts that foreground
how the categories of illness are expanding to include a broadening range of experi-
ences that can be treated medically (see Arney, & Menjivar, 2014; Conrad, 1992, 2005;
Healy, 2006; Moynihan, Doran, & Henry, 2008; Moynihan et  al., 2002). Focusing on
the biomedical construction within advertisements for antidepressants speciﬁcally, re-
searchers have shown that exposure to such advertisements can impact perceptions
of depression and its treatment (An, Jin, & Brown, 2009). Speciﬁcally, An and col-
leagues (2009) found that individuals who had higher levels of exposure to antide-
pressant advertisements tended to have more positive perspectives of using
antidepressants and positioned these medications as a primary treatment for depres-
sion, though this impact was found to be at least partly mediated by prior experience
with depression.
Several researchers have explored the impact of the constructions of depression
and its treatment in DTC advertisements for antidepressants, though ﬁndings have
been mixed. For example, Corrigan, Kosyluk, Fokuo, and Park (2014) found that mem-
bers of the public who were exposed to a Cymbalta (antidepressant) advertisement
were “less likely to offer them [individuals with a mental illness] help, more likely to
view them as dangerous, and more likely to endorse social avoidance” (p.  797), though
the researchers observed an opposite pattern among those with a mental illness. At
the same time, Ball, Liang, and Lee (2014) found that, though the advertisements they
reviewed did not present overt messages that could undermine stigmatizing miscon-
ceptions about mental illness, these ads did present information on prevalence, which
could reduce stigma through normalizing the diagnosis of depression.
A biomedical conception of depression provides a dominant cultural discourse
through which depression is framed, and it is evident from the discussion above that
advertisements for antidepressants tend to reify this model. Exemplifying the cultural
availability of this biomedical discourse, Sigurdson and McMullen (2013) showed that,
when talking about the controversy of the over- and under-diagnosis of depression
and its treatment with antidepressants, individuals often made a distinction between
“real” medical depression and normal experiences of distress. Further, these individuals
also emphasized the importance of medical treatment for “real” or serious depression.
Although some scholars have argued that a biomedical construction of mental illness
might help reduce stigma, others have contended that this model does not relate to
level of stigma and could even be linked to an increase in stigma as deﬁned, for exam-
ple, as the amount of preferred social distance from individuals with a mental illness,
and “perceptions of dangerousness” (Angermeyer, Holzinger, Carta, & Schomerus,
2011; Pescosolido, Martin, Long, Medina, Phelan, & Link, 2010, p.  1322). Further, many
scholars have claimed that the cultural categories of illness have been expanding to
encompass a broadening range of experiences, some of which might have previously
been considered “normal” (Conrad, 1992, 2005; Healy, 2006; Moynihan et  al., 2002,
2008). There is also evidence that a discourse critical of medicalization has entered
public talk (Moynihan et  al., 2008; Moynihan & Henry, 2006).
As such, the discourses about depression and treatment within DTC antidepres-
sant advertisements, and how the public interacts with these culturally available dis-
courses, are not inconsequential. Many scholars have discussed the content of these
advertisements (see An & Kang, 2011; Ball et  al., 2014) and have explored how indi-
viduals interact with them, but researchers have typically used survey and question-
naire methods, which are valuable, but could be further nuanced through in-depth
qualitative study (see Alperstein, 2014; Park, Ju, & Kim, 2014; Wood & Cronley, 2014).
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Based on this gap within the literature, the main question of this research project is
“How do women negotiate the presentations of depression in DTC televised advertise-
ments for antidepressants?”
Methods
For our study, we conducted semi-structured focus groups with women in
Saskatchewan, Canada. Wilkinson (1998) argued that focus groups are ideal for ex-
ploring talk in relation to meanings of health and illness and for in-depth discussion.
Krueger and Casey (2009) stated that a “focus group presents a more natural environ-
ment than that of an individual interview because participants are inﬂuencing and in-
ﬂuenced by others” (p.  7). Though we do not agree that focus groups are necessarily
more “natural,” this interactive component ﬁts well with our emphasis on how pre-
sentations of depression are negotiated. Although focus groups can contribute to the
researcher(s) having less control in data collection, which can be considered an issue
or limitation of this method (see Krueger & Casey, 2009; Wilkinson, 1998), Wilkinson
(1998) argued that this lessened control can actually be valuable in a context where
one is interested in exploring participants’ language use and meaning construction.
Recruitment
We recruited participants through the use of printed posters, which we placed on bul-
letin boards at the local university, on outdoor bulletin boards throughout the down-
town core, and in some local businesses. We also used online advertisements on the
University of Saskatchewan’s announcements and on the community events section
of Kijiji. We provided $20 compensation to each participant.
Participants
After participants communicated interest in taking part in the study, we individually
administered (via email or phone) a brief demographic questionnaire (with questions
such as age, length of time living in the area). We limited the demographic information
we collected to help maintain participant conﬁdentiality, due to the potentially sensi-
tive nature of the topic, and also because we were not interested in aggregating this in-
formation to make group-based claims. In total, we recruited 27  participants.
Since some researchers have positioned adult women as a potential target audi-
ence of DTC drug advertisements (Brownﬁeld et  al., 2013), we recruited only women
(18+  years of age). Focus group composition by age was as follows: group  1 (26, 28, 32,
34, 35), group  2 (18, 26, 26, 26, 29), group  3 (24, 24, 25, 26, 27), group  4 (32, 37, 38, 51),
group  5 (19, 23, 28), and group  6 (35, 38, 40, 41, 55), with a mean age of 31.2  years and
a range of 18 to 55. We offered one set of focus groups to women who were younger,
and one set to women who were older in the event that age might be helpful in un-
derstanding our data; however, we did not focus on age for the analysis in this article.
We executed the age “grouping” in a ﬂexible manner based on the age range of par-
ticipants who indicated interest in taking part in the study. In addition to this age con-
sideration, we offered the participants pre-set focus group options (usually 2) on a
ﬁrst come, ﬁrst serve basis until each group was full.
Materials
We chose three advertisements for participants to interact with: one advertisement
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each for Cymbalta, Zoloft, and Pristiq. We chose these advertisements based on avail-
ability and researcher familiarity with the campaigns as well as their varied content.
In a content analysis of DTC prescription drug advertisements on television, Ball and
colleagues’ (2014) sample included advertisements for Cymbalta, which could indicate
the relevance of the advertisement campaign. Further, the Cymbalta advertisement
we chose demonstrated multiple individuals in varying contexts as experiencing de-
pression, which provided multiple potential constructions of depression for the par-
ticipants to interact with. Additionally, in a study in which An and Kang (2011)
analyzed print advertisements for stigmatized illnesses over a 10-year period, adver-
tisements for both Cymbalta and Zoloft occurred, which, again, indicates their rele-
vance. Moreover, the Zoloft advertisement we chose is one that has been uniquely
associated with antidepressant medication (i.e., through a stylized ﬁgure). We included
the Pristiq advertisement because we had seen various iterations of it and because it
portrayed a woman with depression in a different context (i.e., at work).
In total, the Cymbalta advertisement was approximately one minute 16  seconds
long. Discussion of risks and side effects began at 22  seconds and continued until just
before the end of the advertisement. The main slogans of the advertisement empha-
sized that depression hurts. The advertisement started by listing some symptoms of
depression. Within the advertisement there were three main scenarios: a woman get-
ting out of bed looking gloomy and dishevelled; a man at a social gathering but not
engaging; and a woman sitting in a chair looking very upset, and minimally engaging
with her dog. As the discussion of Cymbalta’s risks and side effects began, there was a
transition in the experiences of the three focal characters; they seemed “happier” and
able to “engage” more. The advertisement ended by recommending that the listener
consult her or his physician. We used the following link to access the advertisement:
http://www.ispot.tv/ad/7V1E/ cymbalta-depression-symptoms.
The Zoloft advertisement was approximately one minute in length. The discussion
of risks and side effects started at about 36  seconds and continued until just before
the end of the advertisement. The main character was an oval-shaped white cartoon
ﬁgure that looked glum and was being followed by a grey cloud raining on it. A blue
bird ﬂew around the character chirping, but the character did not interact. Depression
was constructed as potentially relating to levels of neurochemicals (i.e., an imbalance),
which the medication helped to regulate. This was demonstrated through a visual di-
agram of neurochemical transmission, though the narrator stated that the sources of
depression have not been identiﬁed. Following the presence of medication, the cloud
started to dissipate, and the cartoon character began jumping forward, smiling, and
acknowledging the blue bird. The advertisement again ended with a directive that the
listener should consult her or his physician. The Zoloft advertisement can be found
at: https://www.youtube.com/watch?v=twhvtzd6gXA.
Like the Cymbalta ad, the Pristiq advertisement was approximately one minute
16  seconds long. The discussion of risks and side effects started at 35  seconds and con-
tinued until near the end of the advertisement. The central character appeared to be
an African-American woman working in a shop. The advertisement opened with her
describing her depression and how she had to wind herself up frequently (a metaphor
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demonstrated through the ad imagery of a windup doll). The advertisement empha-
sized that depression was biological through the use of a diagram showing how the
medication was hypothesized to work on neurochemical transmission. It ended with
an emphasis on Pristiq as integral to the woman’s getting well (as evidenced by her
smiling and working in her shop), and by encouraging the listener to consult her or
his physician. The Pristiq advertisement can be found at http://www.youtube.com
/watch?v=uVNZ8ZBP5gY.
Procedures
This project was approved by the research ethics board of our university. The focus
groups took place in a private room in a community centre in a city in the Canadian
Prairies. After listening to a verbal overview of the study, participants completed con-
sent forms. As mentioned, all groups were semi-structured, and they were one to two
hours in duration. The moderator (CB) used a question guide to encourage initial dis-
cussion as well as prompts based on participants’ talk. Questions from the guide in-
clude the following samples:
What is your impression of this advertisement?1
What struck you in particular about the advertisement?2
In this advertisement, they show images of individuals with depression3
before and after treatment. What is your reaction to the depiction of de-
pression before treatment?
What is your sense of the extent to which this depiction of depression4
ﬁts your overall perception of depression?
In this advertisement, the focus is on the individual depicted as suffering5
from depression despite having a seemingly normal or enjoyable life.
What is your reaction to this depiction of depression?
The moderator altered ordering and wording of the questions based on the focus
group discussion. If a question was answered before the moderator asked it, the mod-
erator did not ask the question directly, but instead prompted the participants to say
more. Group  4 viewed only the Cymbalta and Zoloft advertisements due to time, while
all other groups viewed all three advertisements in varying orders. Discussion occurred
following each advertisement, and there was a summary discussion at the end of the
session. 
Data collection
We audio-recorded the focus groups, and a male note-taker recorded the speaking
order. We then transcribed all audio-recordings verbatim and used the transcript no-
tation presented by Lafrance (2009; see the Appendix). We removed identifying in-
formation and used numbers (1 to 5) to refer to participants. Following each excerpt,
we included, in square brackets, the number of the focus group (1 to 6) and the name
of the drug in the immediately preceding advertisement that was viewed by the par-
ticipants (i.e., [1  Cymbalta]).
Methodology
We adopted a social constructionist position, which focuses on the co-constructive,
contextual, and ﬂexible nature of meaning, and eschews the notion that there is one
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truth that can be accessed (Burr, 1995). This position ﬁt with the method of analysis
of our study as well as with our goals, which were to explore talk without evaluation
of its “truthfulness.”
Given this position and our research goals and question, our analysis consisted of
the approach to discourse analysis presented by Potter and Wetherell (1987), Potter
(1996), and Wood and Kroger (2000), in which the performative and constructive na-
ture of talk was emphasized. As such, the questions of “how  … discourse is put to-
gether, and what is gained by this construction” (Potter & Wetherell, 1987, p.  160)
guided our analysis. We focused on participants’ uses of various discursive devices,
such as wording and sentence structure, to explore how language was used and the
potential consequences of these uses of language. The analysis consisted of several
readings of the transcripts (often while listening to the audio-recording), the search
for relevant sections of the transcript that were speciﬁc to our research question, and
the extraction of these sections for in-depth analysis.
Analysis/Results
Within the focus groups, the women undermined the claims to depression and “nor-
mal” within the advertisements, which opened space for them to stake their own
(counter)claims to these categories, which they did both overtly and covertly. In what
follows, we delineate how participants used speciﬁc discursive devices and resources
(e.g., word choice, sentence structure, arguments) to accomplish these moves (see
Potter, 1996, for a discussion of the use of discursive devices to undermine and defend
claims). We demonstrate how, through this critical engagement with the advertise-
ments, the women reclaimed normal, reclaimed depression, and demonstrated caution
in defence of their claims, which also introduced ambiguity in relation to the deﬁni-
tions of what constitutes normal and depression.
Reclaiming normal
The implied claims to normal made by the advertisements were often troubled and
undermined by the women through various linguistic resources. For example, the
women both directly and indirectly constructed ways the advertisements blur the line
between normal and pathological. We deduce our reference to “normal” from the par-
ticipants’ discursive positioning(s) of the categories they were constructing as general
or common. Speciﬁcally, the women made reference to grief and sadness, stress, gen-
eral hurting, lacking energy, feeling bad, or a general lack of productivity, which they
often downplayed or trivialized in a way that emphasized their normalcy. By doing so,
they reclaimed “normal” from the risk of being positioned as pathological through
the advertisement’s claims.
In this excerpt, rather than simply saying that the experience in the advertisement
does not warrant antidepressants, the participants discuss a normalized way that the
experience could be treated.
CB: […] How does that metaphor: [of the windup doll] for depression kind
of ﬁt with how you understand depression, kind of thing.
1: it doesn’t ﬁt for me at a:ll:, like it— it really doesn’t, I think that’s—
that’s r— be somethin:g: you would give if you’re advertising those 
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24-hour energy drinks or whatever they are, you know what I mean [3:
((laughs))], like kind of like you are just tired and don’t want to [3: yeah]—
but for depression it is no:t, it’s— yeah, right!— =
3: = like you don’t have energy and— or you don’t want to do something
then you have to make yourself to do something [1: yeah:], it’s like wind-
ing up, you just ((someone laughs)) [1: yeah] like, ok, I have to clean up
my house [1: yeah ((laughs))], ok ((laughs)) I  just have to go and do that.
1: you don’t need an antidepressant, you need a cup of coffee, like
((laughs)) it’s just, I don’t know  … out of touch from what Iwould think.
[5  Pristiq].
Here, we see an instance in which the participants strengthened their claims, in-
cluding to normal, through collaboration and consensus. For example, they did not
directly refute each other’s claims, but worked together in constructing a joint claim
to normal.
On several occasions the participants communicated that the advertisement did
not ﬁt with how they viewed depression (and through contrast, “normal”). Note the
use of extrematization (“using the extreme points on relevant descriptive dimensions”
[Potter, 1996, p.  187]) and emphasis to express a lack of “ﬁt” of the presentation in the
advertisement and the participants’ constructions: “It doesen’t … at a:ll:,” “out of
touch,” and “reallydoesn’t.” The disconnection between the representation of depres-
sion in the advertisement and the participants’ accounts set the tone for the subse-
quent reclaiming of “normal.”
A clear positioning of the experiences (i.e., a lack of energy) as “normal” is evident
through the women’s references to how the experiences could be addressed (e.g., with
a cup of coffee). It can be assumed that this reference to normalized and minimized
treatments by the women implies the treatment of something common. Further, “not
being able to do what you need to do” was positioned by the participants as a reference
to choice or something under personal control, which might relate more to character
(e.g., laziness) than pathology.
In the next excerpt, the participants speciﬁcally reclaim “normal” by discussing
a rejection of the medicalization of stress or sadness. 
1: I guess a person::?  … u::m who is::— would have some stressor or
some sort of other, maybe for a week, or ﬁve days, or he is feeling sad for
ﬁve days, after seeing this thing, he mi:ght think that  … he needs to take
some medication, or he won’t get over it without the medication? [4:
yeah] I— I think that’s— that’s  … not  … that’s not fa:i:r—
4: —I think that should be included, that [1: yea:h] time frame, because
there is a time frame [1  Cymbalta]
Reference to stress and sadness works to associate the presentation in the adver-
tisement with common experiences (i.e., to normalize it; see Potter, 1996 for a discus-
sion of normalization). Further, saying that it is “not fair” that treatment of sadness
and stress would be medicalized emphasizes the distance between experiences that
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are constructed by the women as normal versus pathological. Additionally, the partic-
ipants say that the advertisement positions medication as necessary in the context of
such experiences as “sad[ness],” and they are critical of this positioning. It is implied
that the advertisement is abnormalizing normal experiences (i.e., through medical-
ization; see Potter, 1996, for a discussion of abnormalizing). The participants also at-
tempt to undermine the claims in the advertisement by arguing that they do not
provide complete information (e.g., on time frame). In  doing so, they subtly present
(counter)claims about what constitutes normal (i.e., sadness for a few days) and re-
position what is presented in the advertisement as normal.
Reclaiming depression
The focus group participants frequently trivialize and downplay the presentations of
depression in the advertisements through, for example, claiming that they reﬂect
something like the ﬂu or a  cold, sadness, a  lack of energy, a  lack of productivity, and
anxiety, but not depression. In this way, the participants construct the advertisements
as falling short in their claims to depression. In  contrast to the claims in the advertise-
ments, the women construct their own (counter)claims to depression in an “attempt”
to “reclaim” it as severe, uncommon, and serious.
In the following excerpt, the participants engage with the notion of stake (i.e., vested
interest; see Potter, 1996) in their rather complex construction of the advertisement.
1: […] I quite like the adverts, but it was quite va:gu:e, you know, it didn’t
sa::y what level of depression you have to be::? O::r  … you know, so how
long the effectswould last afterwards, and…
CB: M: yeah … anybody else?… Kind of your impression of uhm: depression
after treatment, and how it is represented kind of thing?…
3: that if you take this pill it will just go awa:y [1: yea:h] [CB: M:], and you
will just go back to  … a happy life of, or whatever, you— [1: a  British cup
of tea] yeah, that it will just— it will just go awa::y, that it will just make
it go away, kind of disappear.
CB: Kind of how does that ﬁt with how you perceive kind of antidepressant
treatment as working kind of thing
1: Really, an— against what my perception of it is, yeah […], I thi— it is
certainly advertising it like a ﬂu:, but like it— if you have a co:l:d, you
know, it is like you take these tablets and you will be better in ﬁve da:y:s:,
you know, it— They are advertising it like that, but for me depression is
nothing like that, it— it is much more longer ter::m [4  Zoloft] 
Though the women critically engage with the advertisement, such as by construct-
ing its messages as vague and not ﬁtting their perception of depression and treatment,
participant  1 does indicate that she “likes” the advertisement, at least in some regards.
As such, this excerpt demonstrates that, though there is criticism of the messages in
the advertisements, conversation within the focus groups is not solely negative toward
them. At the same time, the women in this excerpt jointly undermine the advertise-
ment’s claims to depression, and (re)claim depression as severe and serious.
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Participant 1 starts to undermine the advertisement’s claims through constructing
them as vague, and through contrasting that the ease of treatment of depression por-
trayed in the advertisement is literally opposite to or “against” her perception. Nearing
the end of the excerpt, we can see the culmination of this critical interaction with a
more direct criticism of the advertisement’s claims to depression itself, and the pro-
duction of a more direct (counter)claim by the women. For example, participant  1
makes a comparison between the presentation of depression in the advertisement
and the “ﬂu” or a “cold.” Having the ﬂu or a cold are medical aberrations from the
“healthy body,” though relatively common experiences. A cold and the ﬂu also tend
to be, in general, fairly banal and easily treated. This ease of treatment is also referenced
in the participant’s construction of a relatively quick “healing” time. So, the presenta-
tion of the dis-ease in the advertisement is positioned by the women as a common ex-
perience and, as such, is normalized and minimized (see Potter, 1996, for a discussion
of these discursive moves). This reference to a cold and the ﬂu builds on participant  3’s
criticism of the advertisement’s claim—that it portrays an ease of treatment (i.e., the
depression just disappears with treatment).
This reference to a cold and the ﬂu becomes particularly relevant when consider-
ing that participant  1 states that “depression is nothing like that.” Participant  1 uses
extrematization (i.e., “nothing like that”) to undermine the advertisement’s presen-
tation and support a counter-claim, which further builds on her claim that the ease of
treatment in the advertisement literally opposes her perception. As such, in contrasting
depression and the presentation in the advertisement, the women construct depres-
sion as something beyond a cold and the ﬂu, something more serious or severe. Also
note participant  1’s use of “much more” in reference to “longer term.” This reference
to quantity in the context of temporality emphasizes the difference in severity between
depression and the alternative experiences presented in the advertisement.
The criticizing of the advertisement, and undermining of its claims, is further sup-
ported by participant  1’s use of the word “advertising.” Her use of this word fore-
grounds the stakes in the presentation of depression and treatment in the
advertisement—to sell a product. Citing the potential intentionality in the presentation
of depression raises the possibility that the advertisement is not necessarily “unbiased”
and opens up space for the participants’ (counter)claims.
In this next excerpt, the participants construct the importance of distinguishing
depression from sadness, as well as the potential detrimental outcomes of this distinc-
tion not being clear.
3: Yeah, I agree. I feel like that’s the education [1: Mhm], is realizing that
depression and sadness that we all feel, that everyoneknows what it’s like
to feel? They’re different, they are very different things? [CB: M:] … […] 
CB: Um … to what extent do you think the ad … differentiates, ’cause you
said kind of there is a difference between sadness and depression kind of
thing?
3: I don’t feel like it addresses that at all [CB: M:] … I feel like that’s what’s
missing? Is that education piece, is helping people understa:nd that
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there’s a difference, and because I th— I  … I don’t know, again, I am kind
of being opinionated ((general laugh)), sorry, but I feel like people will ra-
tionalize to themselves? that this is just sadness, and I should just be able
to get over this, and then, when the day that they can’t get out of bed be-
cause it’s debilitating, that’s when all of a sudden, you know, oh my god,
I can’t get out of bed, I’m stuck, or someone finds them at home and they
haven’t been out of bed for two weeks, you know, like, and I feel like some
of that’s harmful? Some of the mindsets that are perpetuated by some-
thing like this? For one thing that it’s curable by a pill, and for another that
it’s something we all go through, so just  … you know, I don’t know  … ﬁnd
your way through it, or, I don’t know… I don’t know if I am making sense,
or just =
1: = Yeah, cause they don’t really explain, like, they are like, depression
hurts, but they don’t really explain like what depression would be [3:
Right], like, I almost want to say clinical definition, or like [3: That might
help ((laughs))], yeah, like this is kind of normal, this isn’t [3: Mhm]. Like,
if you feel sa::d, every day, you know, and you don’t know why, that
would be more in line with depression than jus:t run-of-the-mill sadness.
Usually because with sadness you have reason, where depression can
be just  … just because = [3  Cymbalta]
The claims to depression in the advertisement are collaboratively undermined by
the participants through their arguments about how the advertisement falls short.
This collaboration, in the form of agreeing with and elaborating on each other’s claims,
strengthens the participants’ claims. The participants make direct claims to how the
advertisements do not make a clear distinction between mental illness and “normal.”
Additionally, some participants, such as participant  1, use extrematization (e.g., “at
all”) to emphasize that the advertisement falls short in its presentation of depression.
Furthermore, the presentation in the advertisement is associated, by the partici-
pants, with a minimized and normalized experience (i.e., sadness), which they contrast
with depression. For example, sadness, beyond being a normalized experience itself,
is referred to, by participant  1, as “just run-of-the-mill.” “Just” works to downplay or
minimize sadness relative to depression, as well as abnormalize depression through
contrast. Participant  3 continually makes reference to there being a “clear” difference
between depression and sadness, adding strength to participant  1’s claims through
elaboration and consensus. This difference is also highlighted through the participants’
tonal emphasis, direct stating of difference, and speciﬁcation of the portrayal as “very”
different from depression. Through their claiming that the advertisement does not
make this distinction clear and constructing individuals who do not acknowledge it
as lacking education, the credibility of the advertisement is questioned in a way that
allows space for the women to stake their own (counter)claims to depression.
Through the women’s juxtaposition of depression with sadness that “we all feel,”
it can be assumed that they are positioning depression as not something we all feel
(i.e., as abnormal). Emphasizing that depression is not universally or commonly ex-
perienced draws attention to the severity (through rarity) of depression. Further,
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through attempting to articulate the difference between sadness and depression, par-
ticipant  1 cautiously (e.g., through the use of hedges such as “almost,” “kind of”) relies
on a medical association (“clinical deﬁnition”), which works to support her claims;
invoking medical terminology strengthens her (counter)claims, which include reiter-
ating depression as serious. 
Caution in the defence of claims: The introduction of ambiguity
Although a logical extension of the above analyses might consist of determining the
women’s joint deﬁnition of “depression” and “normal,” the participants often leave
these categories relatively “blurry” and “open,” despite staking claims to them.
Structurally, various forms of hedging and vagueness introduce ambiguity into the
conversations. For example, the ﬁrst-person singular is often used by participants in a
way that leaves the categories open to alternative accounts. Further, uncertainty is in-
troduced by the women through hesitation, vague statements, and the use of “I don’t
know.” In addition, notions of degrees of severity, types of depression, and a compar-
ison between depression and alternative experiences, for example, allow the partici-
pants to acknowledge alternative accounts as depression, while simultaneously
reclaiming depression as severe, serious, and uncommon. For example, in emphasizing
the severity of depression, there is a risk that milder experiences could be excluded
from the category of depression. But if one constructs a distinction between mild and
severe depression, there is less risk that “mild” experiences will be excluded from de-
pression. At the same time, it should be recognized that these types of claims, though
allowing an acknowledgement of “milder” experiences as depression, could downplay
and trivialize some depression (i.e., constructing some depression as less serious or
severe).
In this next excerpt the participant employs subtle notions of degrees of severity
of depression by contrasting the presentation in the advertisement with more “pro-
found” depression.
3: Um  … it was too: simple to me for— to be connected to the people
that I know [CB: Mm] that have dealt with depression. Um  … and I mean,
I— I— the— obviously there is different … levelsprobably, of depression
as well, but [CB: Mm] somebody  … like, whenever I have been around
someone who has been profo:u:ndly depressed, they can’t  … I mean,
they— I don’t even think that would register as a— it’s like— it’s all-con-
suming, it is not like it is something that is separate really, it is just [CB:
Mm] “This is who I am, this is  … this is the way it is, this is my reality
right now,” so I don’t know that, like I said again, I feel like it would be–
it is an easier thing for someone to understand that is not depressed? if
you look at it that way [CB: Mm] um … I don’t know [6  Zoloft] 
While the participant reclaims depression as something serious and “profound”
(contrasted with the presentation in the advertisement), she does so without com-
pletely rejecting the existence of experiences of depression that might be less severe
or “simpler,” or that might match the construction within the advertisement. For ex-
ample, though the participant notes that the presentation within the advertisement
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is “too simple,” and “wouldn’t register” with people she knows who have depression,
opening up the presentation to being positioned as not depression, she states,
“Obviously there is different … levels probably, of depression.” This reference to the
possibility of “levels” of depression works to leave open the potential acknowledge-
ment of a “simpler” or less “profound” experience of depression as still being depres-
sion, though the participant seems to simultaneously criticize this form of depression
(bordering on refuting the advertisement’s portrayal of depression). As such, this ref-
erence to degrees of severity works to introduce vagueness about what depression is
and whether the portrayal in the advertisement can be considered depression.
Further, the positioning of “knowledge” as being obtained through close experi-
ence with depression leaves open the category of depression to alternative interpreta-
tions and also provides category entitlement (see Potter, 1996). For example, in noting
“whenever I have been around,” the participant leaves space open for her experience
with depression to not fully encompass depression. For example, perhaps people she
knows with depression are different when she is not around them. At the same time,
this use of vagueness introduces a space for alternative claims to depression to be ac-
knowledged without her claim to depression necessarily being undermined completely.
Further, her reference to close personal experience with depression provides a defence
of her claims to depression through the mobilization of category entitlement. For ex-
ample, people who have personal experience with depression, even if not having been
depressed themselves, can be seen as more entitled to make claims to depression, since
they are not speaking from a complete lack of experience.
Discussion
The women’s generally critical tone in their engagement with these DTC advertise-
ments is consistent with literature indicating that consumers can be active, skeptical
viewers of such ads (Alperstein, 2014; Arney et  al., 2013; Bell et  al., 2010; Joseph et  al.,
2008). In addition, it is also quite likely that this critical tone was, in part, a product of
our recruitment strategy and our method of data generation. For example, Alperstein
(2014) found that “young adults” (those between 18 and 24 years of age) generally
“hold decidedly negative attitudes” (p.  242) toward this category of advertising.
Although most individuals in our sample fell outside this age range, over half were
under the age of 30. In addition, focus groups are a context in which participants often
take up and refute each other’s positions; so it is perhaps not surprising that the par-
ticipants fashioned arguments, some of which were critical of the advertisements.
As we have shown in our analysis, the women’s engagement with the advertise-
ments demonstrates an implied threat to both normal and depression within the ad-
vertisements, as well as a potential tension in the discourses surrounding mental
illness. Further, though there has been discussion within academia about how these
advertisements medicalize experience and therefore expand categories of illness into
areas that could be considered “normal” (see Arney et  al., 2014), the present research
brings to light how the advertisements can be interacted with as if they also threaten
the category of depression (i.e., through trivializing it). This notion of the advertise-
ments potentially “threatening” depression is indirectly supported by researchers who
have indicated that exposure to some antidepressant advertisements has been associ-
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ated with greater stigma of mental illness among the public (Corrigan et  al., 2014).
Some of the speciﬁc stigma-supporting attitudes that individuals endorsed included
being more likely to support social avoidance of individuals with a mental illness, and
to position them as dangerous. Although Corrigan and colleagues (2014) did not ex-
plicitly discuss trivialization, our research indicates that trivialization might also be an
important concept to consider when exploring why or how interacting with these ad-
vertisements might contribute toward the stigmatizing of mental illness among mem-
bers of the public. At the same time, Corrigan and colleagues (2014) found that
exposure was associated with improved perceptions of people with a mental illness
when those who were exposed to the advertisements reported having a mental illness
(Corrigan et  al., 2014). Through considering the past and present diagnostic status of
our participants, we might have further nuanced our analysis.
Reclaiming normal
The women’s speciﬁc reclaiming of normal could demonstrate the accessibility of dis-
courses of medicalization (e.g., Arney et  al., 2014; Conrad, 1992; Moynihan et  al., 2002,
2008). Given that notions of medicalization have entered public discourse (Arney et  al.,
2014; Conrad, 1992, 2005; Moynihan et al., 2002, 2008), it is not surprising that the
women would invoke this talk when engaging with the advertisements. Further, as
medicalization can be positioned as a form of social control (Conrad, 1992), resistance
to the advertisements’ medicalizing claims can also work to resist broadening social
control, particularly by the pharmaceutical industry and biomedicine in general.
At the same time, the women walked a ﬁne line between reclaiming normal and
minimizing experiences of depression. For example, through indicating that the ad-
vertisements were portraying normal experiences, the women opened themselves up
to accusations that they were trivializing or minimizing others’ experiences of depres-
sion that ﬁt the advertisements’ portrayals. This risk can be seen in some of the
women’s defensive talk while reclaiming normal and in their use of hedging. Anti-
stigma campaigns in Canada emphasize the importance of not trivializing depression
(see Canadian Mental Health Association, 2015, and Pathstone Mental Health, 2014,
for examples of anti-stigma campaigns in Canada). As such, the women’s talk, includ-
ing their potential resistance to medicalization, could be problematic from the per-
spective of anti-stigma talk. Further, the potential negative positioning of the speaker,
should she be noted as using stigma talk, could bring into question her claims and
open them up to criticism or refutation. 
Reclaiming depression
There might also be a link between the women’s reclaiming of depression and dis-
courses of medicalization, though with a different focus than in the context of reclaim-
ing normal. Speciﬁcally, the medicalization within the advertisements (see Arney et  al.,
2014; Conrad, 1992, 2005) might threaten to trivialize depression. Arguments related
to medicalization position the advertisements as expanding the category of mental ill-
ness, which arguably invites more individuals to associate their experiences with the
illness (see Arney et  al., 2014; Conrad, 1992; Moynihan et  al., 2002, 2008). Although
some scholars speculate that normalizing mental illness could be associated with less
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stigma (see Ball et  al., 2014), the women’s talk indicates how expanding this category
could threaten to trivialize depression by lowering the threshold of severity for what
constitutes depression, and making diagnoses of depression more common and per-
haps subject to charges of questionable validity. This notion of a threat to depression
is clariﬁed and poignantly reﬂected in the following quote from the popular autobiog-
raphy of a woman’s experience with depression, Prozac Nation (Wurtzel, 1995). In the
epilogue of the autobiography, Wurtzel (1995) stated,
I can’t get away from some sense that after years of trying to get people to
take depression seriously  … now it has gone beyond the point of recogni-
tion as a real problem to become something that appears totally trivial. …
Every so often, I ﬁnd myself with the urge to make sure people know
that  … I am a real sicko, a depressive of a much higher order than all these
happy-pill poppers with their low-level sorrow. (pp.  341–342)
Returning to a Canadian context, the women’s defending against the risk of trivi-
alization and minimization of depression is in line with some messages in anti-stigma
campaigns related to mental illness in Canada, which emphasize avoiding trivializing
mental illness (see Bell Canada, 2015; Canadian Mental Health Association, 2015;
Pathstone Mental Health, 2014). We do not intend to imply that the women were ref-
erencing or had viewed the speciﬁc campaigns we highlighted, but do want to suggest
parallels in how the women engaged with the medicalizing claims within the adver-
tisements and some anti-stigma talk about mental illness in Canada.
Caution in the defence of claims: The introduction of ambiguity
This discursive pattern provides evidence of uncertainties surrounding what consti-
tutes mental illness. For example, in light of the availability of medicalizing discourses
(see Conrad, 1992; Moynihan et  al., 2002, 2008), the line between mental health and
illness can be relatively ambiguous and ﬂuid. For example, the word “depression” can
be used as both a signiﬁer for everyday experiences of being “down” and as shorthand
for major depressive disorder (McMullen & Conway, 2002). This ambiguity also reﬂects
the risky discursive moves the women were making (i.e., possibly being seen as mini-
mizing or trivializing depression while reclaiming normal and depression).
Future directions
We chose to use the three DTC antidepressant advertisements in this study based, to
some extent, on availability. It will be important to explore whether women interact
in a similar fashion with other antidepressant advertisements, including those cur-
rently being aired. Further, we know very little about how men, either in all-men or
mixed-gender focus groups, might negotiate what constitutes depression in these ad-
vertisements.
We also recommend undertaking a similar project in which information related
to the participants’ experience(s) with and views of depression and its treatment, as
well as their familiarity with advertisements for antidepressants, is collected and con-
sidered. It is quite possible that people might interact differently with such advertise-
ments depending on such experience(s) (see An et  al., 2009). Within our focus groups,
a few participants informally made evident that they had close experiences with de-
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pression and treatment. For example, they talked about knowing someone who had
depression, having had depression themselves, or having taken antidepressants. Based
on this participant information, and the evidence from the literature that experience
with depression might interact with the impact of DTC antidepressant advertisements
(An et  al., 2009), it is possible that our focus group conversations were shaped, in part,
by these experiences.
Similarly, we did not ask participants about their exposure to DTC drug advertise-
ments. Previous research has shown that those who have more exposure to these types
of advertisements view the use of antidepressants more positively (An et  al., 2009).
As such, level of exposure might be implicated in how the women in this study inter-
acted with the advertisements. Future research might beneﬁt from inquiring about
level of experience with the advertisements in order to further contextualize how par-
ticipants interact with and make meaning of them.
Acknowledgements
We would like to acknowledge the contributions of the women who volunteered to
participate in this study. CB’s work on this research was facilitated by a CIHR Frederick
Banting and Charles Best  Canadian Graduate Scholarship.
References
Alperstein, Neil M. (2014). Awareness of and attitudes towards direct-to-consumer prescription drug
advertising among young adults. Health Marketing Quarterly, 31, 231–245. doi:  10.1080
/07359683.2014.936291
An, Soontae, Jin, Hyun S., & Brown, Jane D. (2009). Direct-to-consumer antidepressant ads and
young adults’ beliefs about depression. Health Marketing Quarterly, 26, 259–278.
doi:  10.1080/07359680903303981
An, Soontae, & Kang, Hannah. (2011). Stigma-reducing components in direct-to-consumer prescrip-
tion ads: Onset controllability, offset controllability, and recategorization. Health
Communication, 26, 468–478. doi:  10.1080/10410236.2011.554169
Angermeyer, Matthias C., Holzinger, Anita, Carta, Mauro G., & Schomerus, Georg. (2011). Biogenetic
explanations and public acceptance of mental illness: Systematic review of population stud-
ies. British Journal of Psychiatry, 199, 367–372. doi:  10.1192/bjp.bp.110.085563
Arney, Jennifer, & Menjivar, Cecilia. (2014). Disease mongering in direct-to-consumer advertising
and the expansion of the antidepressant market. Sociological Inquiry, 84, 519–544.
doi:  10.1111/soin.12062
Arney, Jennifer, Street, Richard L. Jr., & Naik, Aanand D. (2013). Consumers’ various and surprising
responses to direct-to-consumer advertisements in magazine print. Patient Preference and
Adherence, 7, 95–102.
Ball, Jennifer G., Liang, Angie, & Lee, Wei-Na. (2014). Potential for stigma reduction through direct-
to-consumer prescription drug advertising: An exploratory content analysis of television
commercials. Journal of Current Issues & Research in Advertising, 35, 190–208. doi:  10.1080
/10641734.2014.900289
Bell, Robert A., Taylor, Laramie D., & Kravitz, Richard L. (2010). Do antidepressant advertisements
educate consumers and promote communication between patients with depression and
their physicians? Patient Education and Counselling, 81, 245–250. doi:  10.1016/j.pec.2010
.01.014
Bell Canada. (2015). 5 simple ways to help end the stigma around mental illness. URL: http://letstalk
.bell.ca/en/news/52/bell-lets-talk-the-5-simple-ways-to-help-fight-the-stigma-around-men-
tal-illness [April  20, 2015].
Brownfield, Erica D., Bernhardt, Jay M., Phan, Jennifer L., Williams, Mark V., & Parker, Ruth  M. (2013).
Direct-to-consumer drug advertisements on network television: An  exploration of quantity,
740 Canadian Journal of Communication, Vol 42 (5)
frequency, and placement. Journal of Health Communication: International Perspectives, 9,
491–497. doi:  10.1080/10810730490523115
Burr, Vivien. (1995). An introduction to social constructionism. London: Routledge.
Canadian Mental Health Association. (2015). Stigma and discrimination. URL http://ontario.cmha.ca
/documents/stigma-and-discrimination/ [April  20, 2015]. 
Conrad, Peter. (1992). Medicalization and social control. Annual Review of Sociology, 18, 209–232.
Conrad, Peter. (2005). The shifting engines of medicalization. Journal of Health and Social Behavior,
46, 3–14.
Corrigan, Patrick W., Kosyluk, Kristin A., Fokuo, J. Konadu, & Park, Jin H. (2014). How does direct
to consumer advertising affect the stigma of mental illness? Community Mental Health
Journal, 50, 792–799. doi:  10.1007/s10597-014-9698-7
Greenslit, Nathan P., & Kaptchuk, Ted J. (2012). Antidepressants and advertising: Psychopharmaceuticals
in crisis. Yale Journal of Biology and Medicine, 85, 153–158.
Grow, Jean M., Park, Jin S., & Han, Xiaoqi. (2006). ‘Your life is waiting!’: Symbolic meanings in di-
rect-to-consumer antidepressant advertising. Journal of Communication Inquiry, 30, 163–188.
Healy, David. (2006). The latest mania: Selling bipolar disorder. PloS Medicine, 3(4), 1–4. doi:  10.1371
/journal.pmed.0030185
Iizuka, Toshiaki, & Jin, Ginger Z. (2005). The effect of prescription drug advertising on doctor visits.
Journal of Economics and Management Strategy, 14, 701–727.
Joseph, Mathew, Spake, Deborah F., & Finney, Zachary. (2008). Consumer attitudes toward pharma-
ceutical direct-to-consumer advertising: An  empirical study and the role of income.
International Journal of Pharmaceutical and Healthcare Marketing, 2, 117–133. doi: 10.1108
/17506120810887916
Krueger, Richard A., & Casey, Mary Anne. (2009). Focus groups: A practical guide for applied research
(4th  ed.). Thousand Oaks, CA: Sage.
Lafrance, Michelle L. (2009). Women and depression: Recovery and resistance. New York, NY: Routledge.
Lock, Margaret. (2012). From genetics to postgenomics and the discovery of the new social body. In
M.C. Inhorn & E.A. Wentzell (Eds.), Medical anthropology at the intersection: Histories, ac-
tivisms, and futures (pp.  129–160). Durham, NC: Duke University Press.
McMullen, Linda M., & Conway, John B. (2002). Conventional metaphors for depression. In  S.R.
Fussell (Ed.), Verbal communication of emotions: Interdisciplinary perspectives (pp.  167–181).
Mahwah, NJ: Lawrence Erlbaum Associates.
Mintzes, Barbara. (2006). Direct-to-consumer advertising of prescription drugs in Canada: What are
the public health implications? Health Council of Canada: Taking the pulse. URL:
http://www.healthcouncilcanada.ca/rpt_det.php?id=160 [April  20, 2015].
Mintzes, Barbara, Barer, Morris L., Kravitz, Richard L., Bassett, Ken, Lexchin, Joel, Kazanjian,
Arminée,  Evans, Robert G., Pan, Richard, & Marion, Stephen A. (2003). How does direct-to-
consumer advertising (DTCA) affect prescribing? A survey in primary care environments
with and without legal DTCA. Canadian Medical Association Journal, 169, 405–412.
Moynihan, Ray, Doran, Evan, & Henry, David. (2008). Disease mongering is now part of the global
health debate. PLoS Medicine, 5, e106. doi: 10.1371/journal.pmed.0050106
Moynihan, Ray, Heath, Iona, & Henry, David. (2002). Selling sickness: The pharmaceutical industry
and disease mongering. British Medical Journal, 324, 886–890.
Moynihan, Ray, & Henry, David. (2006). The fight against disease mongering: Generating knowledge
for action. PLoS Medicine, 3, e191. doi:  10.1371/journal.pmed.0030191
Park, Jin S., Ju, Ilwoo, & Kim, Kenneth E. (2014). Direct-to-consumer antidepressant advertising and
consumers’ optimistic bias about the future risk of depression: The moderating role of ad-
vertising skepticism. Health Communication, 29, 586–597. doi:  10.1080/10410236.2013.785318
Pathstone Mental Health. (2014). Top 11 myths about mental illness. URL: http://www.mendthemind
.ca/stigma/top-11-myths-about-mental-illness [April  20, 2015].
Pescosolido, Bernice A., Martin, Jack K., Long, J. Scott, Medina, Tait R., Phelan, Jo C., & Link, Bruce
G. (2010). ‘A disease like any other’? A decade of change in public reactions to schizophrenia,
depression, and alcohol dependence. American Journal of Psychiatry, 167, 1321–1330. 
Babineau, McMullen, & Downe Negotiating What Constitutes Depression 741
Potter, Jonathan. (1996). Representing reality: Discourse, rhetoric and social construction. Thousand
Oaks, CA: Sage.
Potter, Jonathan, & Wetherell, Margaret. (1987). Discourse and social psychology: Beyond attitudes
and behaviour. London: Sage Publications.
Pratt, Laura, Brody, Debra J., & Gu, Qiuping. (2011). Antidepressant use in persons aged  12 and over:
United States, 2005–2008. NCHS Data Brief, 76, 1–8. URL: http://www.cdc.gov/nchs/data
/databriefs/db76.pdf [April  20, 2015].
Sigurdson, Kristjan J., & McMullen, Linda M. (2013). Talking controversy: Long-term users of anti-
depressants and the diagnosis of depression. Qualitative Research in Psychology, 10, 428–444. 
Singh, Tanuja, & Smith, Donnavieve. (2005). Direct-to-consumer prescription drug advertising:
A  study of consumer attitudes and behavioral intentions. Journal of Consumer Marketing,
22, 369–378. doi:  10.1108/07363760510631101
Wilkinson, Sue. (1998). Focus groups in health research: Exploring the meaning of health and illness.
Journal of Health Psychology, 3, 329–348. doi:  10.1177/135910539800300304
Wood, Kelly S., & Cronley, Maria L. (2014). Then and now: Examining how consumer communica-
tion and attitudes of direct-to-consumer pharmaceutical advertising have changed in the
last decade. Health Communication, 29, 814–825. doi:  10.1080/10410236.2013.803437
Wood, Linda A., & Kroger, Rolf O. (2000). Doing discourse analysis: Methods for studying action in
talk and text. Thousand Oaks, CA: Sage.
Wurtzel, Elizabeth. (1995). Prozac nation: Young and depressed in America. New York, NY: Penguin.
742 Canadian Journal of Communication, Vol 42 (5)
Appendix: Transcript notation
Source: Adapted from Lafrance (2009)
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Symbol Indication
CB: What was your 
impression…
The moderator’s speech
We:ll A word sound was elongated (more colons for further elongation)
Bold font Emphasis was placed on the word or sound
— A participant’s communication stopped abruptly
(( )) Enclosed our description of a non-word sound
. A period is “a stopping fall in tone” (p. 207)
? “A rising inflection” (p. 207)
! “An animated or emphatic tone” (p. 207)
2: I would agree with
your [assessment 
3: yeah, me too,] I would
have to agree as well
Square brackets here enclosed times where individuals spoke over
each other
[…] A part of the extract was excluded
… A pause in speech (more for a longer pause)
= “at the end of a
speaker’s utterance and
at the start of the next ut-
terance”
“The absence of a discernible gap” (p. 206) between their speech
“turns”
